Scenarios that move TARS

Tarsus Pharmaceuticals, Inc. - Common Stock

Scenarios that move TARS: 1 analysis, 1 positive, 0 negative.

  1. · Opus Genetics receives FDA approval for presbyopia eye drop — ▲ · impact +10 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing